AI Verdict
ZTS has stronger fundamentals based on our AI analysis.
ELV vs ZTS Fundamental Comparison
| Metric | ELV | ZTS |
|---|---|---|
| Revenue | $199.1B | $9.5B |
| Net Income | $5.7B | $2.7B |
| Net Margin | 2.8% | 28.2% |
| ROE | 12.9% | 80.2% |
| ROA | 4.7% | 17.3% |
| Current Ratio | 1.54x | 3.03x |
| Debt/Equity | 0.73x | 2.71x |
| EPS | $25.21 | $6.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ELV vs ZTS: Frequently Asked Questions
Is ELV or ZTS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ZTS has stronger fundamentals. ELV is rated BUY (75% confidence) while ZTS is rated BUY (78% confidence). This is not investment advice.
How does ELV compare to ZTS fundamentally?
Elevance Health, Inc. has ROE of 12.9% vs Zoetis Inc.'s 80.2%. Net margins are 2.8% vs 28.2% respectively.
Which stock pays higher dividends, ELV or ZTS?
ELV has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ELV or ZTS for long term?
For long-term investing, consider that ELV has BUY rating with 75% confidence, while ZTS has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ELV vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ELV vs ZTS, the AI consensus favors ZTS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.